New Antiepileptic Drugs: Review on Drug Interactions
Authors:
- Isabelle Ragueneau-MajlessiIRIsabelle Ragueneau-Majlessi
- Rene H. LevyRLRene H. Levy
- 1 February 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 24 (1) , 91-103
Abstract
During the Past decade, nine new antiepileptic drugs (AEDs) namely, Felbamate, Gabapentin, Levetiracetam, Lamotrigine, Oxcarbazepine, Tiagabine, Topiramate, Vigabatrin and Zonisamide have been marketed worldwide. The introduction of these drugs increased appreciably the number of therapeutic combinations used in the treatment of epilepsy and with it, the risk of drug interactions. In general, these newer antiepileptic drugs exhibit a lower potential for drug interactions than the classic AEDs, like phenytoin, carbamazepine and valproic acid, mostly because of their pharmacokinetic characteristics. For example, vigabatrin, levetiracetam and gabapentin, exhibit few or no interactions with other AEDs. Felbamate, tiagabine, topiramate and zonisamide are sensitive to induction by known anticonvulsants with inducing effects but are less vulnerable to inhibition by common drug inhibitors. Felbamate, topiramate and oxcarbazepine are mild inducers and may affect the disposition of oral contraceptives with a risk of failure of contraception. These drugs also inhibit CYP2C19 and may affect the disposition of phenytoin. Lamotrigine is eliminated mostly by glucuronidation and is susceptible to inhibition by valproic acid and induction by classic AEDs such as phenytoin, carbamazepine, phenobarbital and primidone.Keywords
This publication has 112 references indexed in Scilit:
- Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New TechniqueThe Journal of Clinical Pharmacology, 2000
- Effect of Felbamate on Clobazam and Its Metabolite Kinetics in Patients With EpilepsyTherapeutic Drug Monitoring, 1999
- Identification of Modified Atropaldehyde Mercapturic Acids in Rat and Human Urine after Felbamate AdministrationChemical Research in Toxicology, 1997
- Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant TherapyEpilepsia, 1997
- Effect of Felbamate on the Pharmacokinetics of LamotrigineThe Journal of Clinical Pharmacology, 1996
- Efficacy and Tolerability of Vigabatrin in Children with Refractory Partial Seizures: A Single‐Blind Dose‐Increasing StudyEpilepsia, 1995
- Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein bindingBrain and Development, 1995
- From the Food and Drug Administration1994
- Absence of interaction between oxcarbazepine and erythromycinActa Neurologica Scandinavica, 1992
- Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial SeizuresEpilepsia, 1989